Connection

Thomas Keane to Neoplasms, Hormone-Dependent

Back to Details
This is a "connection" page, showing publications Thomas Keane has written about Neoplasms, Hormone-Dependent.
Thomas Keane
Connection Strength
0.117
Neoplasms, Hormone-Dependent
  1. Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer. Eur Urol. 2015 Feb; 67(2):334-41.
    View in: PubMed
    Score: 0.117
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.